Abdullah AlSaleh

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 8

Top Topics

Anaerobic Digestion

Replacement Therapy

Methicillin Resistant Staphylococcus Aureus

Top Venues

Access microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Abdullah AlSaleh, Mohammad Shahid, Eman Farid, Khalid M Bindayna
The Effect of Ascorbic Acid and Nicotinamide on Panton-Valentine Leukocidin Cytotoxicity: An Ex Vivo Study. Toxins 15 (1) (2023)
Abdullah AlSaleh, Mohammed Shahid, Eman Farid, Nermin Kamal, Khalid Bindayna
Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCC mec type IV methicillin-resistant Staphylococcus aureus (MRSA). Access microbiology 5 (2) (2023)
Abdullah AlSaleh, Mohammad Shahid, Eman Farid, Khalid M Bindayna
The Effect of Ascorbic Acid and Nicotinamide on Panton-Valentine Leukocidin Cytotoxicity: An Ex Vivo Study. Toxins 15 (1) (2023)
Abdullah AlSaleh, Mohammad Shahid, Eman Farid, Khalid M Bindayna
The Effect of Ascorbic Acid and Nicotinamide on Panton-Valentine Leukocidin Cytotoxicity: An Ex Vivo Study. Toxins 15 (1) (2023)
Abdullah AlSaleh, Mohammad Shahid, Eman Farid, Khalid M Bindayna
The Effect of Ascorbic Acid and Nicotinamide on Panton-Valentine Leukocidin Cytotoxicity: An Ex Vivo Study. Toxins 15 (1) (2023)
Abdullah AlSaleh, Mohammad Shahid, Eman Farid, Khalid M Bindayna
The Effect of Ascorbic Acid and Nicotinamide on Panton-Valentine Leukocidin Cytotoxicity: An Ex Vivo Study. Toxins 15 (1) (2023)
Abdullah AlSaleh, Mohammad Shahid, Eman Farid, Khalid M Bindayna
The Effect of Ascorbic Acid and Nicotinamide on Panton-Valentine Leukocidin Cytotoxicity: An Ex Vivo Study. Toxins 15 (1) (2023)
Abdullah AlSaleh, Mohammed Shahid, Eman Farid, Nermin Kamal, Khalid Bindayna
Synergistic antimicrobial effect of ascorbic acid and nicotinamide with rifampicin and vancomycin against SCC mec type IV methicillin-resistant Staphylococcus aureus (MRSA). Access microbiology 5 (2) (2023)